Srinivas Akkaraju - Jun 1, 2024 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role
Director
Signature
/s/ Todd Rosenthal, as attorney-in-fact
Stock symbol
SYRS
Transactions as of
Jun 1, 2024
Transactions value $
$0
Form type
4
Date filed
6/4/2024, 04:41 PM
Previous filing
May 23, 2024
Next filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYRS Common Stock Options Exercise +4K +150.04% 6.67K Jun 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYRS Restricted Stock Units Options Exercise $0 -4K -100% $0.00* 0 Jun 1, 2024 Common Stock 4K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit ("RSU") award.
F2 Each RSU represents the contingent right to receive one share of the issuer's common stock.
F3 These RSUs vested in their entirety on the first anniversary of the date of grant of the award.